Acitretin (Soriatane) may improve outcomes for cancer patients with multikinase inhibitor (MKI)-mediated hand-foot skin reaction (HFSR), according to a small retrospective study. Of eight MKI users ...

A new review found little high-quality evidence for the management of hand–foot skin reaction (HFSR) associated with regorafenib (Stivarga, Bayer), so the study authors prepared expert advice for ...

Transfer of Communication Skills to the Workplace: Impact of a 38-Hour Communication Skills Training Program Designed for Radiotherapy Teams In this randomized, open-label trial, 871 patients with ...

Sex differences in toxicities and survival outcomes among patients with stage III colorectal cancer receiving adjuvant fluoropyrimidine monotherapy: A pooled analysis of four randomized controlled ...

Please provide your email address to receive an email when new articles are posted on . The use of vascular endothelial growth factor receptor tyrosine kinase inhibitors significantly increased the ...

Hand–foot–skin reaction (HFSR) is an adverse event frequently observed during treatment with capecitabine (cape). In the present analysis, we sought to evaluate the potential association of HFSR and ...

An extensive literature review has found that side effects from regorafenib like redness and swelling may be undertreated. Also included in this study are recommendations from experienced oncologists ...

With the advent of tyrosine kinase inhibitors (TKIs) for the targeted chemotherapy of malignant neoplasms such as thyroid, pancreatic, gastric, bladder, and renal cell carcinoma, [1] dermatologists ...